NCT00389090 2012-02-09A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic GliomaKeryx / AOI Pharmaceuticals, Inc.Phase 2 Terminated32 enrolled